Cargando…

The Prolonged Diagnostic Pathway of Young Adults (Aged 25–39) with Cancer in the United Kingdom: Results from the Young Adult Cancer Patient Journey Study

Purpose: Teenagers and young adults (TYAs; aged 13–24) experience prolonged intervals to cancer diagnosis. Insight into diagnostic intervals in young adults (YAs; aged 25–39) and subgroups at risk for long intervals is lacking. We investigated the diagnostic pathway of YA cancer patients, examined p...

Descripción completa

Detalles Bibliográficos
Autores principales: Soomers, Victorien L. M. N., Lidington, Emma, Sirohi, Bhawna, Gonzalez, Michael A., Darlington, Anne-Sophie, van der Graaf, Winette T. A., Husson, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540185/
https://www.ncbi.nlm.nih.gov/pubmed/34682769
http://dx.doi.org/10.3390/jcm10204646
_version_ 1784588926144479232
author Soomers, Victorien L. M. N.
Lidington, Emma
Sirohi, Bhawna
Gonzalez, Michael A.
Darlington, Anne-Sophie
van der Graaf, Winette T. A.
Husson, Olga
author_facet Soomers, Victorien L. M. N.
Lidington, Emma
Sirohi, Bhawna
Gonzalez, Michael A.
Darlington, Anne-Sophie
van der Graaf, Winette T. A.
Husson, Olga
author_sort Soomers, Victorien L. M. N.
collection PubMed
description Purpose: Teenagers and young adults (TYAs; aged 13–24) experience prolonged intervals to cancer diagnosis. Insight into diagnostic intervals in young adults (YAs; aged 25–39) and subgroups at risk for long intervals is lacking. We investigated the diagnostic pathway of YA cancer patients, examined patient and tumor characteristics associated with its length, and compared the patient interval length of our sample with a TYA cohort. Methods: In this cross-sectional survey YAs diagnosed with cancer in the UK in the past five years completed a questionnaire describing their patient (time from first symptom to first doctor consultation) and healthcare interval (from first consultation until consultation with a cancer specialist), sociodemographic, and clinical characteristics. Associations between characteristics and interval length were examined and compared with previously published data in TYAs. Results: Among 341 YAs the patient interval lasted ≥2 weeks, ≥1 month, and ≥3 months in 60%, 42%, and 21%, respectively, compared to 48%, 27%, and 12% in the TYA group. The healthcare interval lasted ≥2 weeks, ≥1 month, and ≥3 months in 62%, 40%, and 17% of YA patients, respectively. YAs with melanoma or cervical cancer were most likely to experience long intervals, whereas YAs with breast cancer and leukemia were most likely to experience short intervals. Conclusions: Most YAs were not seen by a cancer specialist within 2 weeks of GP consultation. Interval lengths in YAs were associated with cancer diagnosis. Patient intervals were longer among YAs than among TYAs. Our study highlights long diagnostic pathways among YAs and calls for more awareness among healthcare professionals about malignancies in this age group.
format Online
Article
Text
id pubmed-8540185
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85401852021-10-24 The Prolonged Diagnostic Pathway of Young Adults (Aged 25–39) with Cancer in the United Kingdom: Results from the Young Adult Cancer Patient Journey Study Soomers, Victorien L. M. N. Lidington, Emma Sirohi, Bhawna Gonzalez, Michael A. Darlington, Anne-Sophie van der Graaf, Winette T. A. Husson, Olga J Clin Med Article Purpose: Teenagers and young adults (TYAs; aged 13–24) experience prolonged intervals to cancer diagnosis. Insight into diagnostic intervals in young adults (YAs; aged 25–39) and subgroups at risk for long intervals is lacking. We investigated the diagnostic pathway of YA cancer patients, examined patient and tumor characteristics associated with its length, and compared the patient interval length of our sample with a TYA cohort. Methods: In this cross-sectional survey YAs diagnosed with cancer in the UK in the past five years completed a questionnaire describing their patient (time from first symptom to first doctor consultation) and healthcare interval (from first consultation until consultation with a cancer specialist), sociodemographic, and clinical characteristics. Associations between characteristics and interval length were examined and compared with previously published data in TYAs. Results: Among 341 YAs the patient interval lasted ≥2 weeks, ≥1 month, and ≥3 months in 60%, 42%, and 21%, respectively, compared to 48%, 27%, and 12% in the TYA group. The healthcare interval lasted ≥2 weeks, ≥1 month, and ≥3 months in 62%, 40%, and 17% of YA patients, respectively. YAs with melanoma or cervical cancer were most likely to experience long intervals, whereas YAs with breast cancer and leukemia were most likely to experience short intervals. Conclusions: Most YAs were not seen by a cancer specialist within 2 weeks of GP consultation. Interval lengths in YAs were associated with cancer diagnosis. Patient intervals were longer among YAs than among TYAs. Our study highlights long diagnostic pathways among YAs and calls for more awareness among healthcare professionals about malignancies in this age group. MDPI 2021-10-11 /pmc/articles/PMC8540185/ /pubmed/34682769 http://dx.doi.org/10.3390/jcm10204646 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Soomers, Victorien L. M. N.
Lidington, Emma
Sirohi, Bhawna
Gonzalez, Michael A.
Darlington, Anne-Sophie
van der Graaf, Winette T. A.
Husson, Olga
The Prolonged Diagnostic Pathway of Young Adults (Aged 25–39) with Cancer in the United Kingdom: Results from the Young Adult Cancer Patient Journey Study
title The Prolonged Diagnostic Pathway of Young Adults (Aged 25–39) with Cancer in the United Kingdom: Results from the Young Adult Cancer Patient Journey Study
title_full The Prolonged Diagnostic Pathway of Young Adults (Aged 25–39) with Cancer in the United Kingdom: Results from the Young Adult Cancer Patient Journey Study
title_fullStr The Prolonged Diagnostic Pathway of Young Adults (Aged 25–39) with Cancer in the United Kingdom: Results from the Young Adult Cancer Patient Journey Study
title_full_unstemmed The Prolonged Diagnostic Pathway of Young Adults (Aged 25–39) with Cancer in the United Kingdom: Results from the Young Adult Cancer Patient Journey Study
title_short The Prolonged Diagnostic Pathway of Young Adults (Aged 25–39) with Cancer in the United Kingdom: Results from the Young Adult Cancer Patient Journey Study
title_sort prolonged diagnostic pathway of young adults (aged 25–39) with cancer in the united kingdom: results from the young adult cancer patient journey study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540185/
https://www.ncbi.nlm.nih.gov/pubmed/34682769
http://dx.doi.org/10.3390/jcm10204646
work_keys_str_mv AT soomersvictorienlmn theprolongeddiagnosticpathwayofyoungadultsaged2539withcancerintheunitedkingdomresultsfromtheyoungadultcancerpatientjourneystudy
AT lidingtonemma theprolongeddiagnosticpathwayofyoungadultsaged2539withcancerintheunitedkingdomresultsfromtheyoungadultcancerpatientjourneystudy
AT sirohibhawna theprolongeddiagnosticpathwayofyoungadultsaged2539withcancerintheunitedkingdomresultsfromtheyoungadultcancerpatientjourneystudy
AT gonzalezmichaela theprolongeddiagnosticpathwayofyoungadultsaged2539withcancerintheunitedkingdomresultsfromtheyoungadultcancerpatientjourneystudy
AT darlingtonannesophie theprolongeddiagnosticpathwayofyoungadultsaged2539withcancerintheunitedkingdomresultsfromtheyoungadultcancerpatientjourneystudy
AT vandergraafwinetteta theprolongeddiagnosticpathwayofyoungadultsaged2539withcancerintheunitedkingdomresultsfromtheyoungadultcancerpatientjourneystudy
AT hussonolga theprolongeddiagnosticpathwayofyoungadultsaged2539withcancerintheunitedkingdomresultsfromtheyoungadultcancerpatientjourneystudy
AT soomersvictorienlmn prolongeddiagnosticpathwayofyoungadultsaged2539withcancerintheunitedkingdomresultsfromtheyoungadultcancerpatientjourneystudy
AT lidingtonemma prolongeddiagnosticpathwayofyoungadultsaged2539withcancerintheunitedkingdomresultsfromtheyoungadultcancerpatientjourneystudy
AT sirohibhawna prolongeddiagnosticpathwayofyoungadultsaged2539withcancerintheunitedkingdomresultsfromtheyoungadultcancerpatientjourneystudy
AT gonzalezmichaela prolongeddiagnosticpathwayofyoungadultsaged2539withcancerintheunitedkingdomresultsfromtheyoungadultcancerpatientjourneystudy
AT darlingtonannesophie prolongeddiagnosticpathwayofyoungadultsaged2539withcancerintheunitedkingdomresultsfromtheyoungadultcancerpatientjourneystudy
AT vandergraafwinetteta prolongeddiagnosticpathwayofyoungadultsaged2539withcancerintheunitedkingdomresultsfromtheyoungadultcancerpatientjourneystudy
AT hussonolga prolongeddiagnosticpathwayofyoungadultsaged2539withcancerintheunitedkingdomresultsfromtheyoungadultcancerpatientjourneystudy